Experience

Logik.ai Announces Acquisition by ServiceNow

April 3, 2025

Cooley advised Logik.ai, an industry leader offering a modern, artificial intelligence (AI)-powered, composable configure, price and quote solution, on its acquisition by ServiceNow (NYSE: NOW), the AI platform for business transformation.

Read more

Related contacts

Sepideh Mousakhani
Partner, Palo Alto
Jon Gavenman
Partner, Palo Alto
Sangitha Palaniappa
Associate, Palo Alto
Megan Browdie
Partner, Washington, DC
Caitlin Courtney
Partner, Palo Alto
Ross Eberly
Partner, Santa Monica
Stella Sarma
Partner, Brussels
Timothy Shapiro
Partner, Palo Alto
Steve Tonsfeldt
Partner, Palo Alto
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Bryan Berman
Special Counsel, Colorado
Stacey A. Bradford
Special Counsel, Washington, DC
Sharon Connaughton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Kristin O'Hanlon
Special Counsel, San Francisco
Karen Tsai
Special Counsel, Washington, DC
Tamara Chin Loy
Associate, Washington, DC
Joshua Elefant
Associate, Palo Alto
Yichen Liu
Associate, Palo Alto
Michael Pelle
Associate, New York
Breanna Qin
Associate, Palo Alto
Erica Russell
Associate, San Francisco
Kealan Santistevan
Associate, Palo Alto
Megan Stallworth
Associate, Palo Alto
Christopher Suhler
Associate, Colorado
Chris Rhem
Paralegal Specialist, San Francisco
Katie Kissner
Quantitative Analyst, San Francisco
Brian Mitchell
Transactional Quantitative Analyst, San Diego

Related Practices & Industries

LFX Venture Partners Invests in Pipe17’s $15.5 Million Series A Financing

January 13, 2025

Cooley advised LFX Venture Partners, a knowledge-based investor focusing on first, middle, and last-mile cutting-edge technologies and disruptive business models that drive innovation in the global value chain, on its investment in Pipe17’s $15.5 million Series A financing round. Partner Sale Kwon led the Cooley team advising LFX Venture Partners.

Related contacts

Sale Kwon
Partner, Palo Alto
Yichen Liu
Associate, Palo Alto
Megan Stallworth
Associate, Palo Alto
Annie Froehlich
Partner, Washington, DC
Dillon Martinson
Special Counsel, Washington, DC

Related Practices & Industries

Samsung Venture Investment Corporation Invests in Pison Technology

January 7, 2025

Cooley advised Samsung Venture Investment Corporation – the corporate venture capital arm of Samsung Group, based in Seoul, South Korea – on its investment in Pison Technology. Partner Sale Kwon led the Cooley team advising Samsung Venture Investment Corporation, which frequently invests in technology companies in various sectors, including the semiconductor, telecommunications, software, internet, bioengineering and medical sectors, across Europe, Asia and North America.

Related contacts

Sale Kwon
Partner, Palo Alto
Yichen Liu
Associate, Palo Alto
Megan Stallworth
Associate, Palo Alto

Related Practices & Industries

ArsenalBio Closes Oversubscribed $325 Million Series C

September 4, 2024

Cooley advised Arsenal Biosciences (ArsenalBio), a clinical-stage programmable cell therapy company focused on engineering advanced chimeric antigen receptor T-cell (CAR-T) therapies for solid tumors, on the close of its oversubscribed $325 million Series C financing round.

Read more

Related contacts

Josh Seidenfeld
Partner, Palo Alto
Sara Semnani
Partner, Santa Monica
Megan Browdie
Partner, Washington, DC
Annie Froehlich
Partner, Washington, DC
Christopher Kimball
Partner, Washington, DC
Kevin King
Partner, Washington, DC
John Sellers
Senior Counsel, Palo Alto
Shannon MacMichael
Special Counsel, Washington, DC
Julia Gage
Associate, San Francisco
Emily Lee
Associate, Palo Alto
Megan Stallworth
Associate, Palo Alto
Rubin Waranch
Associate, Colorado
Jake Ironfield
Transactional Quantitative Analyst, New York

Related Practices & Industries

New Enterprise Associates Leads Brenig Therapeutics’ $65 Million Series A

July 23, 2024

Cooley advised New Enterprise Associates (NEA), a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies. as the lead investor in Brenig Therapeutics’ $65 million Series A financing. Brenig is a pioneering neurology-focused drug development company utilizing an artificial intelligence/machine learning (AI/ML)-based discovery platform for the treatment of Parkinson’s disease. Partner Josh Seidenfeld led the Cooley team advising NEA.

Related contacts

Josh Seidenfeld
Partner, Palo Alto
Thomas Heiser
Associate, Palo Alto
Megan Stallworth
Associate, Palo Alto

Related Practices & Industries

Admissions and credentials

California

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.